Further processing options
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7)
Saved in:
Journal Title: | Journal of Translational Medicine |
---|---|
Authors and Corporations: | , , , , , , , , , |
In: | Journal of Translational Medicine, 12, 2014, Suppl 1, p. O7 |
Type of Resource: | E-Article |
Language: | English |
published: |
Springer Science and Business Media LLC
|
Subjects: |